93 related articles for article (PubMed ID: 3780986)
1. A phase II study to evaluate tamoxifen in pancreatic adenocarcinoma.
Crowson MC; Dorrell A; Rolfe EB; Fielding JW
Eur J Surg Oncol; 1986 Dec; 12(4):335-6. PubMed ID: 3780986
[TBL] [Abstract][Full Text] [Related]
2. Adenocarcinoma of the pancreas--a hormone sensitive tumor? A preliminary report on Nolvadex treatment.
Theve NO; Pousette A; Carlström K
Clin Oncol; 1983 Sep; 9(3):193-7. PubMed ID: 6616993
[TBL] [Abstract][Full Text] [Related]
3. [Tamoxifen for metastatic pancreatic adenocarcinoma: a complete response].
Lamy R; Conroy T; Brunaud L; Bresler L
Gastroenterol Clin Biol; 2001 Oct; 25(10):912-3. PubMed ID: 11852397
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen therapy in unresectable adenocarcinoma of the pancreas.
Wong A; Chan A; Arthur K
Cancer Treat Rep; 1987; 71(7-8):749-50. PubMed ID: 3038316
[TBL] [Abstract][Full Text] [Related]
5. The beneficial effect of tamoxifen therapy in patients with resected adenocarcinoma of the pancreas.
Horimi T; Takasaki M; Toki A; Nishimura W; Morita S
Hepatogastroenterology; 1996; 43(11):1225-9. PubMed ID: 8908555
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen in unresectable hypernephroma. A phase II trial and review of the literature.
Weiselberg L; Budman D; Vinciguerra V; Schulman P; Degnan TJ
Cancer Clin Trials; 1981; 4(2):195-8. PubMed ID: 7249256
[TBL] [Abstract][Full Text] [Related]
7. [Concomitant arterial infusion chemotherapy with tamoxifen therapy for hepatic metastases from pancreatic adenocarcinoma--a preliminary report].
Saito H; Takamura A; Sakurai Y; Horio K; Ohta T; Yamano M; Sawaguchi Y; Sato Y
Gan To Kagaku Ryoho; 1993 Nov; 20(14):2177-82. PubMed ID: 8239683
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of tamoxifen in patients with advanced renal cell carcinoma.
Glick JH; Wein A; Torri S; Alavi J; Harris D; Brodovsky H
Cancer Treat Rep; 1980; 64(2-3):343-4. PubMed ID: 7407768
[No Abstract] [Full Text] [Related]
9. Phase II evaluation of melphalan in adenocarcinoma of the pancreas.
Smith DB; Kenny JB; Scarffe JH; Maley WV
Cancer Treat Rep; 1985; 69(7-8):917-8. PubMed ID: 4016799
[No Abstract] [Full Text] [Related]
10. Phase II trial of cyclophosphamide, leucovorin, 5-fluorouracil 24-hour infusion and tamoxifen in pancreatic cancer.
Eckel F; Lersch C; Lippl F; Assmann G; Schulte-Frohlinde E
J Exp Clin Cancer Res; 2000 Sep; 19(3):295-300. PubMed ID: 11144522
[TBL] [Abstract][Full Text] [Related]
11. Phase II evaluation of diaziquone in pancreatic carcinoma: a Southwest Oncology Group Study.
Tilchen EJ; Fleming T; Mills G; Oishi N; Bonnett JD; Natale RB; Harker G; Coltman CA
Cancer Treat Rep; 1987 Dec; 71(12):1309-10. PubMed ID: 3690548
[No Abstract] [Full Text] [Related]
12. Phase II evaluation of mitoguazone in cancers of the esophagus, stomach, and pancreas: a Southeastern Cancer Study Group Trial.
Ravry MJ; Omura GA; Hill GJ; Bartolucci AA; Velez-Garcia E
Cancer Treat Rep; 1986 Apr; 70(4):533-4. PubMed ID: 3698050
[No Abstract] [Full Text] [Related]
13. Phase II clinical study of tamoxifen in advanced endometrial adenocarcinoma: a Gynecologic Oncology Group study.
Slavik M; Petty WM; Blessing JA; Creasman WT; Homesley HD
Cancer Treat Rep; 1984 May; 68(5):809-11. PubMed ID: 6722836
[No Abstract] [Full Text] [Related]
14. Tamoxifen in refractory metastatic carcinoma of the prostate.
Glick JH; Wein A; Padavic K; Negendank W; Harris D; Brodovsky H
Cancer Treat Rep; 1980; 64(6-7):813-8. PubMed ID: 7427966
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of methyl-CCNU in the treatment of advanced pancreatic carcinoma.
Moertel CG; Douglass HO; Hanley J; Carbone PP
Cancer Treat Rep; 1976 Nov; 60(11):1659-61. PubMed ID: 1035508
[No Abstract] [Full Text] [Related]
16. Phase II trial of streptozotocin, mitomycin C, and 5-fluorouracil in adenocarcinoma of the pancreas.
Bukowski RM; Abderhalden RT; Hewlett JS; Weick JK; Groppe CW
Cancer Clin Trials; 1980; 3(4):321-4. PubMed ID: 6448716
[TBL] [Abstract][Full Text] [Related]
17. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of L-asparaginase in the treatment of pancreatic carcinoma.
Lessner HE; Valenstein S; Kaplan R; DeSimone P; Yunis A
Cancer Treat Rep; 1980; 64(12):1359-61. PubMed ID: 7471124
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of infusional fluorouracil, leucovorin, mitomycin, and dipyridamole in locally advanced unresectable pancreatic adenocarcinoma: SWOG S9700.
Isacoff WH; Bendetti JK; Barstis JJ; Jazieh AR; Macdonald JS; Philip PA
J Clin Oncol; 2007 May; 25(13):1665-9. PubMed ID: 17470859
[TBL] [Abstract][Full Text] [Related]
20. [Hormone therapy of postoperative recurrent pancreatic carcinoma with octreotide and tamoxifen].
Wenger FA; Zieren HU; Jacobi CA; Müller JM
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1348-50. PubMed ID: 9931878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
